Clinical stage: stage II (T3-4, N-)

Clinical trials for Clinical stage: stage II (T3-4, N-) explained in plain language.

Never miss a new study

Get alerted when new Clinical stage: stage II (T3-4, N-) trials appear

Sign up with your email to follow new studies for Clinical stage: stage II (T3-4, N-), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Immunotherapy before Chemo-Radiation shows promise for Hard-to-Treat cancers

Disease control Recruiting now

This study is testing whether the immunotherapy drug dostarlimab (TSR-042), followed by standard chemoradiation and surgery, can effectively treat advanced mismatch repair deficient (dMMR) solid tumors. About 212 adults with locally advanced dMMR cancers will receive the drug int…

Matched conditions: CLINICAL STAGE: STAGE II (T3-4, N-)

Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

Clinical stage: stage II (T3-4, N-)

Get alerted when new Clinical stage: stage II (T3-4, N-) trials appear

Immunotherapy before Chemo-Radiation shows promise for Hard-to-Treat cancers